Highly efficient generation of human hepatocyte–like cells from induced pluripotent stem cells

There exists a worldwide shortage of donor livers available for orthotropic liver transplantation and hepatocyte transplantation therapies. In addition to their therapeutic potential, primary human hepatocytes facilitate the study of molecular and genetic aspects of human hepatic disease and development and provide a platform for drug toxicity screens and identification of novel pharmaceuticals with potential to treat a wide array of metabolic diseases. The demand for human hepatocytes, therefore, heavily outweighs their availability. As an alternative to using donor livers as a source of primary hepatocytes, we explored the possibility of generating patient‐specific human hepatocytes from induced pluripotent stem (iPS) cells. Conclusion: We demonstrate that mouse iPS cells retain full potential for fetal liver development and describe a procedure that facilitates the efficient generation of highly differentiated human hepatocyte‐like cells from iPS cells that display key liver functions and can integrate into the hepatic parenchyma in vivo. (HEPATOLOGY 2010.)

[1]  B. Hogan,et al.  Distinct mesodermal signals, including BMPs from the septum transversum mesenchyme, are required in combination for hepatogenesis from the endoderm. , 2001, Genes & development.

[2]  T. Mikkelsen,et al.  Dissecting direct reprogramming through integrative genomic analysis , 2008, Nature.

[3]  S. Duncan,et al.  Development of the mammalian liver and ventral pancreas is dependent on GATA4 , 2007, BMC Developmental Biology.

[4]  Robert Lanza,et al.  Efficient Differentiation of Functional Hepatocytes from Human Embryonic Stem Cells , 2008, Stem cells.

[5]  J. Roder,et al.  Derivation of completely cell culture-derived mice from early-passage embryonic stem cells. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[6]  Yoshiaki Ito,et al.  Fetal liver development requires a paracrine action of oncostatin M through the gp130 signal transducer , 1999, The EMBO journal.

[7]  Liang-Shang Gan,et al.  Effects of prototypical microsomal enzyme inducers on cytochrome P450 expression in cultured human hepatocytes. , 2003, Drug metabolism and disposition: the biological fate of chemicals.

[8]  George Q. Daley,et al.  Disease-Specific Induced Pluripotent Stem Cells , 2008, Cell.

[9]  K. Zaret,et al.  Initiation of mammalian liver development from endoderm by fibroblast growth factors. , 1999, Science.

[10]  Hossein Baharvand,et al.  Differentiation of human embryonic stem cells into hepatocytes in 2D and 3D culture systems in vitro. , 2006, The International journal of developmental biology.

[11]  Shulan Tian,et al.  Induced Pluripotent Stem Cell Lines Derived from Human Somatic Cells , 2007, Science.

[12]  Stephen Dalton,et al.  Activin A Efficiently Specifies Definitive Endoderm from Human Embryonic Stem Cells Only When Phosphatidylinositol 3‐Kinase Signaling Is Suppressed , 2007, Stem cells.

[13]  S. Yamanaka,et al.  Induction of Pluripotent Stem Cells from Mouse Embryonic and Adult Fibroblast Cultures by Defined Factors , 2006, Cell.

[14]  J. Darnell,et al.  Expression of transcription factor HNF-4 in the extraembryonic endoderm, gut, and nephrogenic tissue of the developing mouse embryo: HNF-4 is a marker for primary endoderm in the implanting blastocyst. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[15]  J. Waring,et al.  Isolated human hepatocytes in culture display markedly different gene expression patterns depending on attachment status. , 2003, Toxicology in vitro : an international journal published in association with BIBRA.

[16]  E. Morrisey,et al.  GATA6 Is Essential for Embryonic Development of the Liver but Dispensable for Early Heart Formation , 2005, Molecular and Cellular Biology.

[17]  Catherine Payne,et al.  Highly efficient differentiation of hESCs to functional hepatic endoderm requires ActivinA and Wnt3a signaling , 2008, Proceedings of the National Academy of Sciences.

[18]  E. Kroon,et al.  Efficient differentiation of human embryonic stem cells to definitive endoderm , 2005, Nature Biotechnology.

[19]  T. Ichisaka,et al.  Induction of Pluripotent Stem Cells from Adult Human Fibroblasts by Defined Factors , 2007, Cell.

[20]  M. Grompe.  Principles of therapeutic liver repopulation. , 2006, Journal of inherited metabolic disease.

[21]  David C Hay,et al.  Efficient Differentiation of Hepatocytes from Human Embryonic Stem Cells Exhibiting Markers Recapitulating Liver Development In Vivo , 2008, Stem cells.

[22]  J. Itskovitz‐Eldor,et al.  Differentiation of human embryonic stem cells on three-dimensional polymer scaffolds , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[23]  M. Elazar,et al.  Isolation and Transcriptional Profiling of Purified Hepatic Cells Derived from Human Embryonic Stem Cells , 2008, Stem cells.

[24]  Jaesung Park,et al.  Homogeneous differentiation of hepatocyte‐like cells from embryonic stem cells: applications for the treatment of liver failure , 2008, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[25]  George Q. Daley,et al.  Reprogramming of human somatic cells to pluripotency with defined factors , 2008, Nature.

[26]  K. Plath,et al.  Generation of human induced pluripotent stem cells from dermal fibroblasts , 2008, Proceedings of the National Academy of Sciences.

[27]  R. Fisher,et al.  Human hepatocyte transplantation: worldwide results. , 2006, Transplantation.

[28]  H. Aburatani,et al.  Interpreting expression profiles of cancers by genome-wide survey of breadth of expression in normal tissues. , 2005, Genomics.

[29]  K. Kume,et al.  Differentiation of mouse and human embryonic stem cells into hepatic lineages , 2008, Genes to cells : devoted to molecular & cellular mechanisms.

[30]  H. Baharvand,et al.  Differentiation of human embryonic stem cells into functional hepatocyte-like cells in a serum-free adherent culture condition. , 2008, Differentiation; research in biological diversity.

[31]  A. Granato,et al.  Hepatocyte transplantation as a treatment for glycogen storage disease type 1a , 2002, The Lancet.

[32]  J. Chowdhury,et al.  Therapeutic potential of hepatocyte transplantation. , 2002, Seminars in cell & developmental biology.

[33]  A. Strain.  Isolated hepatocytes: use in experimental and clinical hepatology. , 1994, Gut.

[34]  A. Burlina.  Hepatocyte transplantation for inborn errors of metabolism , 2004, Journal of Inherited Metabolic Disease.